PMID: 41490200
10.1053/j.gastro.2019.05.004 22 MoreS
It binds itself to toxins, heavy metals, and metabolic byproducts, allowing them to be safely and efficiently excreted
I felt a huge difference especially the mornings I took the shot
Why this trial matters: First bispecific + CD38 combo to show superior PFS and OS in Phase III in RRMM Potential new standard of care as early as second-line Demonstrates deep responses, high MRD-negativity, and durable outcomes First-line Strategies in BRAF V600E-Mutant mCRC: Real-World Evidence Signals Treatment Priorities In a real-world retrospective cohort of patients with BRAF V600E-mutant metastatic colorectal cancer (mCRC), frontline chemotherapy plus anti-VEGF therapy was associated with the longest survival outcomes, while BRAF-targeted strategies showed promising response rates, emphasizing the need for tailored therapy and prospective validation
It sits within a broader strategy that may include hormone optimization, lifestyle guidance, and other supports